Pathway Name Avg Num Perturbations Total Perturbations Num Entities Min Mean Truth Max Mean Truth Min Mean Within Max Mean Within Min Mean Any Max Mean Within FOXM1 transcription factor network 80.0 4087.0 51.0 -0.792 0.015 1000.0 -1000.0 -0.138 -1000.0 Glypican 2 network 59.0 238.0 4.0 -0.125 -0.098 1000.0 -1000.0 -0.019 -1000.0 Aurora B signaling 56.0 3809.0 67.0 -0.498 0.015 1000.0 -1000.0 -0.055 -1000.0 Signaling events regulated by Ret tyrosine kinase 55.0 4513.0 82.0 -0.29 0.015 1000.0 -1000.0 -0.066 -1000.0 Calcineurin-regulated NFAT-dependent transcription in lymphocytes 47.0 3216.0 68.0 -0.678 0.339 1000.0 -1000.0 -0.087 -1000.0 Signaling events mediated by the Hedgehog family 44.0 2323.0 52.0 -0.186 0.185 1000.0 -1000.0 -0.034 -1000.0 IL4-mediated signaling events 39.0 3573.0 91.0 -0.805 0.55 1000.0 -1000.0 -0.107 -1000.0 Nongenotropic Androgen signaling 39.0 2055.0 52.0 -0.249 0.138 1000.0 -1000.0 -0.049 -1000.0 Signaling events mediated by Stem cell factor receptor (c-Kit) 38.0 2976.0 78.0 -0.28 0.094 1000.0 -1000.0 -0.049 -1000.0 Reelin signaling pathway 37.0 2097.0 56.0 -0.22 0.038 1000.0 -1000.0 -0.065 -1000.0 Endothelins 36.0 3467.0 96.0 -0.326 0.065 1000.0 -1000.0 -0.059 -1000.0 IGF1 pathway 36.0 2104.0 57.0 -0.251 0.048 1000.0 -1000.0 -0.081 -1000.0 Signaling mediated by p38-alpha and p38-beta 35.0 1564.0 44.0 -0.226 0.015 1000.0 -1000.0 -0.052 -1000.0 TCGA08_p53 34.0 242.0 7.0 -0.162 0.076 1000.0 -1000.0 -0.021 -1000.0 TCGA08_retinoblastoma 34.0 273.0 8.0 -0.235 0.063 1000.0 -1000.0 -0.012 -1000.0 Ephrin A reverse signaling 31.0 221.0 7.0 -0.084 -0.0 1000.0 -1000.0 -0.03 -1000.0 Thromboxane A2 receptor signaling 31.0 3270.0 105.0 -0.183 0.036 1000.0 -1000.0 -0.051 -1000.0 p75(NTR)-mediated signaling 31.0 3930.0 125.0 -0.165 0.044 1000.0 -1000.0 -0.077 -1000.0 Fc-epsilon receptor I signaling in mast cells 31.0 3018.0 97.0 -0.188 0.039 1000.0 -1000.0 -0.067 -1000.0 PLK1 signaling events 30.0 2608.0 85.0 -0.343 0.05 1000.0 -1000.0 -0.035 -1000.0 IL23-mediated signaling events 28.0 1709.0 60.0 -0.611 0.015 1000.0 -1000.0 -0.118 -1000.0 HIF-1-alpha transcription factor network 27.0 2069.0 76.0 -0.32 0.032 1000.0 -1000.0 -0.054 -1000.0 Plasma membrane estrogen receptor signaling 27.0 2369.0 86.0 -0.246 0.114 1000.0 -1000.0 -0.065 -1000.0 Calcium signaling in the CD4+ TCR pathway 26.0 815.0 31.0 -0.286 0.015 1000.0 -1000.0 -0.07 -1000.0 Glypican 1 network 25.0 1217.0 48.0 -0.256 0.034 1000.0 -1000.0 -0.037 -1000.0 PDGFR-alpha signaling pathway 25.0 1119.0 44.0 -0.336 0.032 1000.0 -1000.0 -0.056 -1000.0 Integrins in angiogenesis 25.0 2172.0 84.0 -0.261 0.029 1000.0 -1000.0 -0.08 -1000.0 Rapid glucocorticoid signaling 25.0 517.0 20.0 -0.221 0.034 1000.0 -1000.0 -0.021 -1000.0 Ras signaling in the CD4+ TCR pathway 25.0 429.0 17.0 -0.158 0.02 1000.0 -1000.0 -0.026 -1000.0 Syndecan-1-mediated signaling events 24.0 822.0 34.0 -0.269 0.015 1000.0 -1000.0 -0.044 -1000.0 BMP receptor signaling 24.0 1989.0 81.0 -0.312 0.049 1000.0 -1000.0 -0.074 -1000.0 amb2 Integrin signaling 24.0 2034.0 82.0 -0.337 0.015 1000.0 -1000.0 -0.066 -1000.0 Glucocorticoid receptor regulatory network 24.0 2815.0 114.0 -0.601 0.266 1000.0 -1000.0 -0.064 -1000.0 TCR signaling in naïve CD8+ T cells 23.0 2178.0 93.0 -0.129 0.067 1000.0 -1000.0 -0.064 -1000.0 Neurotrophic factor-mediated Trk receptor signaling 23.0 2805.0 120.0 -0.333 0.19 1000.0 -1000.0 -0.064 -1000.0 RXR and RAR heterodimerization with other nuclear receptor 22.0 1148.0 52.0 -0.307 0.029 1000.0 -1000.0 -0.043 -1000.0 LPA receptor mediated events 22.0 2332.0 102.0 -0.218 0.036 1000.0 -1000.0 -0.067 -1000.0 IL6-mediated signaling events 22.0 1666.0 75.0 -0.249 0.068 1000.0 -1000.0 -0.06 -1000.0 Visual signal transduction: Cones 21.0 828.0 38.0 -0.118 0.017 1000.0 -1000.0 -0.05 -1000.0 Lissencephaly gene (LIS1) in neuronal migration and development 20.0 1124.0 54.0 -0.183 0.03 1000.0 -1000.0 -0.077 -1000.0 S1P5 pathway 20.0 353.0 17.0 -0.152 0.108 1000.0 -1000.0 -0.023 -1000.0 S1P1 pathway 20.0 745.0 36.0 -0.285 0.015 1000.0 -1000.0 -0.05 -1000.0 BCR signaling pathway 20.0 2002.0 99.0 -0.19 0.034 1000.0 -1000.0 -0.069 -1000.0 LPA4-mediated signaling events 18.0 223.0 12.0 -0.168 0.022 1000.0 -1000.0 -0.012 -1000.0 JNK signaling in the CD4+ TCR pathway 18.0 306.0 17.0 -0.158 0.017 1000.0 -1000.0 -0.024 -1000.0 S1P3 pathway 18.0 778.0 42.0 -0.151 0.03 1000.0 -1000.0 -0.025 -1000.0 S1P4 pathway 18.0 462.0 25.0 -0.152 0.029 1000.0 -1000.0 -0.042 -1000.0 Coregulation of Androgen receptor activity 17.0 1332.0 76.0 -0.245 0.031 1000.0 -1000.0 -0.038 -1000.0 IL12-mediated signaling events 17.0 1555.0 87.0 -0.411 0.029 1000.0 -1000.0 -0.098 -1000.0 Aurora A signaling 17.0 1022.0 60.0 -0.344 0.022 1000.0 -1000.0 -0.042 -1000.0 Aurora C signaling 17.0 119.0 7.0 -0.202 0.0 1000.0 -1000.0 -0.029 -1000.0 Class IB PI3K non-lipid kinase events 17.0 51.0 3.0 -0.027 -1000.0 1000.0 -1000.0 -0.014 -1000.0 Arf6 signaling events 15.0 975.0 62.0 -0.251 0.028 1000.0 -1000.0 -0.054 -1000.0 FAS signaling pathway (CD95) 15.0 723.0 47.0 -0.568 0.019 1000.0 -1000.0 -0.037 -1000.0 Angiopoietin receptor Tie2-mediated signaling 15.0 1326.0 88.0 -0.249 0.054 1000.0 -1000.0 -0.092 -1000.0 Osteopontin-mediated events 14.0 547.0 38.0 -0.183 0.015 1000.0 -1000.0 -0.086 -1000.0 Nephrin/Neph1 signaling in the kidney podocyte 13.0 448.0 34.0 -0.043 0.015 1000.0 -1000.0 -0.049 -1000.0 Syndecan-2-mediated signaling events 13.0 939.0 69.0 -0.086 0.036 1000.0 -1000.0 -0.037 -1000.0 Presenilin action in Notch and Wnt signaling 13.0 841.0 61.0 -0.169 0.041 1000.0 -1000.0 -0.058 -1000.0 Canonical Wnt signaling pathway 13.0 677.0 51.0 -0.169 0.081 1000.0 -1000.0 -0.038 -1000.0 Wnt signaling 13.0 97.0 7.0 -0.055 0.015 1000.0 -1000.0 -0.02 -1000.0 Visual signal transduction: Rods 13.0 683.0 52.0 -0.198 0.015 1000.0 -1000.0 -0.073 -1000.0 Sphingosine 1-phosphate (S1P) pathway 12.0 339.0 28.0 -0.152 0.029 1000.0 -1000.0 -0.024 -1000.0 Syndecan-4-mediated signaling events 12.0 845.0 67.0 -0.181 0.022 1000.0 -1000.0 -0.077 -1000.0 ErbB2/ErbB3 signaling events 11.0 727.0 65.0 -0.247 0.025 1000.0 -1000.0 -0.06 -1000.0 Effects of Botulinum toxin 11.0 292.0 26.0 -0.075 0.015 1000.0 -1000.0 -0.056 -1000.0 Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 11.0 375.0 33.0 -0.278 0.043 1000.0 -1000.0 -0.042 -1000.0 Noncanonical Wnt signaling pathway 10.0 281.0 26.0 -0.091 0.015 1000.0 -1000.0 -0.047 -1000.0 Regulation of Androgen receptor activity 10.0 736.0 70.0 -0.25 0.03 1000.0 -1000.0 -0.055 -1000.0 Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 9.0 835.0 85.0 -0.216 0.022 1000.0 -1000.0 -0.059 -1000.0 IL2 signaling events mediated by STAT5 9.0 204.0 22.0 -0.123 0.064 1000.0 -1000.0 -0.022 -1000.0 EGFR-dependent Endothelin signaling events 9.0 198.0 21.0 -0.06 0.022 1000.0 -1000.0 -0.053 -1000.0 Caspase cascade in apoptosis 8.0 650.0 74.0 -0.041 0.044 1000.0 -1000.0 -0.029 -1000.0 ErbB4 signaling events 8.0 563.0 69.0 -0.247 0.036 1000.0 -1000.0 -0.077 -1000.0 Hedgehog signaling events mediated by Gli proteins 8.0 581.0 65.0 -0.152 0.063 1000.0 -1000.0 -0.046 -1000.0 FOXA2 and FOXA3 transcription factor networks 8.0 396.0 46.0 -0.197 0.106 1000.0 -1000.0 -0.036 -1000.0 Nectin adhesion pathway 8.0 546.0 63.0 -0.043 0.03 1000.0 -1000.0 -0.057 -1000.0 IL27-mediated signaling events 8.0 444.0 51.0 -0.25 0.02 1000.0 -1000.0 -0.071 -1000.0 Regulation of nuclear SMAD2/3 signaling 7.0 1022.0 136.0 -0.185 0.066 1000.0 -1000.0 -0.056 -1000.0 IL1-mediated signaling events 7.0 478.0 62.0 -0.1 0.072 1000.0 -1000.0 -0.087 -1000.0 IL2 signaling events mediated by PI3K 7.0 411.0 58.0 -0.182 0.052 1000.0 -1000.0 -0.061 -1000.0 Insulin Pathway 7.0 518.0 74.0 -0.258 0.04 1000.0 -1000.0 -0.072 -1000.0 Cellular roles of Anthrax toxin 6.0 268.0 39.0 -0.096 0.018 1000.0 -1000.0 -0.027 -1000.0 Signaling events mediated by PTP1B 6.0 531.0 76.0 -0.123 0.037 1000.0 -1000.0 -0.061 -1000.0 Signaling events mediated by HDAC Class III 6.0 250.0 40.0 -0.222 0.025 1000.0 -1000.0 -0.038 -1000.0 Role of Calcineurin-dependent NFAT signaling in lymphocytes 6.0 523.0 83.0 -0.269 0.04 1000.0 -1000.0 -0.065 -1000.0 Syndecan-3-mediated signaling events 6.0 242.0 35.0 -0.131 0.044 1000.0 -1000.0 -0.043 -1000.0 Regulation of p38-alpha and p38-beta 6.0 355.0 54.0 -0.147 0.039 1000.0 -1000.0 -0.041 -1000.0 Stabilization and expansion of the E-cadherin adherens junction 6.0 450.0 74.0 -0.246 0.074 1000.0 -1000.0 -0.076 -1000.0 BARD1 signaling events 5.0 289.0 57.0 -0.147 0.045 1000.0 -1000.0 -0.054 -1000.0 a4b1 and a4b7 Integrin signaling 5.0 29.0 5.0 -0.002 0.01 1000.0 -1000.0 -0.015 -1000.0 EPO signaling pathway 5.0 295.0 55.0 -0.042 0.051 1000.0 -1000.0 -0.07 -1000.0 Class I PI3K signaling events mediated by Akt 5.0 390.0 68.0 -0.214 0.058 1000.0 -1000.0 -0.046 -1000.0 Ephrin B reverse signaling 5.0 283.0 48.0 -0.042 0.016 1000.0 -1000.0 -0.06 -1000.0 Regulation of Telomerase 5.0 555.0 102.0 -0.169 0.036 1000.0 -1000.0 -0.087 -1000.0 Signaling events mediated by PRL 5.0 185.0 34.0 -0.103 0.025 1000.0 -1000.0 -0.026 -1000.0 E-cadherin signaling events 5.0 25.0 5.0 -0.013 0.015 1000.0 -1000.0 -0.035 -1000.0 IFN-gamma pathway 4.0 330.0 68.0 -0.176 0.055 1000.0 -1000.0 -0.071 -1000.0 Paxillin-independent events mediated by a4b1 and a4b7 4.0 181.0 37.0 -0.033 0.037 1000.0 -1000.0 -0.046 -1000.0 Signaling mediated by p38-gamma and p38-delta 4.0 67.0 15.0 -0.0 0.032 1000.0 -1000.0 -0.019 -1000.0 EPHB forward signaling 4.0 363.0 85.0 -0.038 0.044 1000.0 -1000.0 -0.079 -1000.0 Arf6 trafficking events 4.0 287.0 71.0 -0.418 0.048 1000.0 -1000.0 -0.065 -1000.0 PDGFR-beta signaling pathway 4.0 390.0 97.0 -0.06 0.058 1000.0 -1000.0 -0.068 -1000.0 PLK2 and PLK4 events 3.0 10.0 3.0 0.005 0.018 1000.0 -1000.0 -0.007 -1000.0 Ceramide signaling pathway 3.0 240.0 76.0 -0.246 0.043 1000.0 -1000.0 -0.04 -1000.0 TRAIL signaling pathway 3.0 186.0 48.0 -0.02 0.047 1000.0 -1000.0 -0.061 -1000.0 Retinoic acid receptors-mediated signaling 3.0 189.0 58.0 -0.081 0.034 1000.0 -1000.0 -0.065 -1000.0 HIV-1 Nef: Negative effector of Fas and TNF-alpha 3.0 157.0 45.0 -0.033 0.066 1000.0 -1000.0 -0.074 -1000.0 TCGA08_rtk_signaling 3.0 90.0 26.0 -0.074 0.045 1000.0 -1000.0 -0.016 -1000.0 E-cadherin signaling in the nascent adherens junction 3.0 232.0 76.0 -0.017 0.056 1000.0 -1000.0 -0.07 -1000.0 Signaling events mediated by HDAC Class II 2.0 177.0 75.0 -0.081 0.037 1000.0 -1000.0 -0.046 -1000.0 Paxillin-dependent events mediated by a4b1 2.0 84.0 36.0 -0.034 0.036 1000.0 -1000.0 -0.058 -1000.0 Class I PI3K signaling events 2.0 172.0 73.0 -0.06 0.037 1000.0 -1000.0 -0.055 -1000.0 E-cadherin signaling in keratinocytes 2.0 97.0 43.0 -0.044 0.047 1000.0 -1000.0 -0.05 -1000.0 p38 MAPK signaling pathway 2.0 109.0 44.0 -0.04 0.044 1000.0 -1000.0 -0.054 -1000.0 Canonical NF-kappaB pathway 1.0 72.0 39.0 -0.03 0.088 1000.0 -1000.0 -0.072 -1000.0 Circadian rhythm pathway 1.0 22.0 22.0 -0.015 0.05 1000.0 -1000.0 -0.034 -1000.0 Insulin-mediated glucose transport 1.0 46.0 32.0 -0.143 0.039 1000.0 -1000.0 -0.052 -1000.0 ceramide signaling pathway 1.0 72.0 49.0 -0.024 0.049 1000.0 -1000.0 -0.037 -1000.0 HIF-2-alpha transcription factor network 1.0 58.0 43.0 -0.159 0.162 1000.0 -1000.0 -0.058 -1000.0 FoxO family signaling 1.0 105.0 64.0 -0.071 0.095 1000.0 -1000.0 -0.049 -1000.0 Signaling events mediated by VEGFR1 and VEGFR2 1.0 213.0 125.0 -0.039 0.096 1000.0 -1000.0 -0.076 -1000.0 Regulation of cytoplasmic and nuclear SMAD2/3 signaling 0.0 10.0 23.0 0.0 0.052 1000.0 -1000.0 -0.044 -1000.0 Arf6 downstream pathway 0.0 6.0 43.0 -0.037 0.038 1000.0 -1000.0 -0.035 -1000.0 mTOR signaling pathway 0.0 50.0 53.0 -0.006 0.04 1000.0 -1000.0 -0.052 -1000.0 Signaling events mediated by HDAC Class I 0.0 65.0 104.0 -0.01 0.064 1000.0 -1000.0 -0.057 -1000.0 Atypical NF-kappaB pathway 0.0 22.0 31.0 -0.0 0.053 1000.0 -1000.0 -0.028 -1000.0 Sumoylation by RanBP2 regulates transcriptional repression 0.0 14.0 27.0 -0.0 0.037 1000.0 -1000.0 -0.038 -1000.0 VEGFR1 specific signals 0.0 50.0 56.0 -0.05 0.07 1000.0 -1000.0 -0.057 -1000.0 Arf1 pathway 0.0 6.0 54.0 -0.003 0.038 1000.0 -1000.0 -0.041 -1000.0 Alternative NF-kappaB pathway 0.0 0.0 13.0 -0.0 0.044 1000.0 -1000.0 -0.028 -1000.0 Total 1983 117228 7203 -23.8318100153 -993.366251732 131000 -131000 -6.89216679631 -131000